Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

An evaluation of the patient education programme for Parkinson’s disease in clinical practice

Identifieur interne : 000398 ( Main/Exploration ); précédent : 000397; suivant : 000399

An evaluation of the patient education programme for Parkinson’s disease in clinical practice

Auteurs : L. E. I. A Ampo [Pays-Bas] ; N. G. A. Spliethoff-Kamminga [Pays-Bas] ; R. A. C. Roos [Pays-Bas]

Source :

RBID : ISTEX:EA530E2F07A55D2E676030393FBE701522F932FE

Abstract

Aim:  The Patient Education Programme for Parkinson’s disease (PEPP) was assessed in a recent randomised controlled trial (RCT). In this study, a trend was identified towards significant improvement of patients’ quality of life (Qol) as well as a significant reduction of caregivers’ psychosocial burden and need for help. This study is aimed at evaluating the effectiveness of the PEPP in clinical practice as compared with the RCT in an academic setting. The second aim is to assess its effectiveness in clinical practice at 6‐month follow‐up. Methods:  Fifty‐five patients and 50 caregivers from nine clinical settings participated in the PEPP consisting of eight weekly sessions of 90 min. Self‐report questionnaires were used to assess patients’ Qol (PDQ‐39) and caregivers’ psychosocial burden and need for help (BELA‐A‐k) at baseline, directly after the programme and at 6‐month follow‐up. To compare the baseline data and short‐term effects, data were used from an RCT study which included 64 Parkinson’s disease patients and 46 caregivers. Results:  Compared with the RCT control group, significant effects, after Bonferoni adjustment, were found for patients’ Qol as well as for caregivers’ psychosocial burden and need for help. No significant changes were found between baseline scores compared with 6‐month follow‐up. Scores returned to baseline levels at 6‐month follow‐up. Conclusions:  Effects from the RCT study were replicated and the effect on patients’ Qol was now significant. However, at 6‐month follow‐up, scores returned to baseline levels, indicating the need for some form of a booster session.

Url:
DOI: 10.1111/j.1742-1241.2011.02765.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">An evaluation of the patient education programme for Parkinson’s disease in clinical practice</title>
<author>
<name sortKey="A Ampo, L E I" sort="A Ampo, L E I" uniqKey="A Ampo L" first="L. E. I." last="A Ampo">L. E. I. A Ampo</name>
</author>
<author>
<name sortKey="Spliethoff Amminga, N G A" sort="Spliethoff Amminga, N G A" uniqKey="Spliethoff Amminga N" first="N. G. A." last="Spliethoff-Kamminga">N. G. A. Spliethoff-Kamminga</name>
</author>
<author>
<name sortKey="Roos, R A C" sort="Roos, R A C" uniqKey="Roos R" first="R. A. C." last="Roos">R. A. C. Roos</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:EA530E2F07A55D2E676030393FBE701522F932FE</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1111/j.1742-1241.2011.02765.x</idno>
<idno type="url">https://api.istex.fr/document/EA530E2F07A55D2E676030393FBE701522F932FE/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001079</idno>
<idno type="wicri:Area/Main/Curation">000E86</idno>
<idno type="wicri:Area/Main/Exploration">000398</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">An evaluation of the patient education programme for Parkinson’s disease in clinical practice</title>
<author>
<name sortKey="A Ampo, L E I" sort="A Ampo, L E I" uniqKey="A Ampo L" first="L. E. I." last="A Ampo">L. E. I. A Ampo</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Centre, Leiden</wicri:regionArea>
<placeName>
<settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Spliethoff Amminga, N G A" sort="Spliethoff Amminga, N G A" uniqKey="Spliethoff Amminga N" first="N. G. A." last="Spliethoff-Kamminga">N. G. A. Spliethoff-Kamminga</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Centre, Leiden</wicri:regionArea>
<placeName>
<settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Roos, R A C" sort="Roos, R A C" uniqKey="Roos R" first="R. A. C." last="Roos">R. A. C. Roos</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Department of Neurology, Leiden University Medical Centre, Leiden</wicri:regionArea>
<placeName>
<settlement type="city">Leyde</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">International Journal of Clinical Practice</title>
<idno type="ISSN">1368-5031</idno>
<idno type="eISSN">1742-1241</idno>
<imprint>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="2011-11">2011-11</date>
<biblScope unit="volume">65</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1173">1173</biblScope>
<biblScope unit="page" to="1179">1179</biblScope>
</imprint>
<idno type="ISSN">1368-5031</idno>
</series>
<idno type="istex">EA530E2F07A55D2E676030393FBE701522F932FE</idno>
<idno type="DOI">10.1111/j.1742-1241.2011.02765.x</idno>
<idno type="ArticleID">IJCP2765</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1368-5031</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Aim:  The Patient Education Programme for Parkinson’s disease (PEPP) was assessed in a recent randomised controlled trial (RCT). In this study, a trend was identified towards significant improvement of patients’ quality of life (Qol) as well as a significant reduction of caregivers’ psychosocial burden and need for help. This study is aimed at evaluating the effectiveness of the PEPP in clinical practice as compared with the RCT in an academic setting. The second aim is to assess its effectiveness in clinical practice at 6‐month follow‐up. Methods:  Fifty‐five patients and 50 caregivers from nine clinical settings participated in the PEPP consisting of eight weekly sessions of 90 min. Self‐report questionnaires were used to assess patients’ Qol (PDQ‐39) and caregivers’ psychosocial burden and need for help (BELA‐A‐k) at baseline, directly after the programme and at 6‐month follow‐up. To compare the baseline data and short‐term effects, data were used from an RCT study which included 64 Parkinson’s disease patients and 46 caregivers. Results:  Compared with the RCT control group, significant effects, after Bonferoni adjustment, were found for patients’ Qol as well as for caregivers’ psychosocial burden and need for help. No significant changes were found between baseline scores compared with 6‐month follow‐up. Scores returned to baseline levels at 6‐month follow‐up. Conclusions:  Effects from the RCT study were replicated and the effect on patients’ Qol was now significant. However, at 6‐month follow‐up, scores returned to baseline levels, indicating the need for some form of a booster session.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Pays-Bas</li>
</country>
<region>
<li>Hollande-Méridionale</li>
</region>
<settlement>
<li>Leyde</li>
</settlement>
</list>
<tree>
<country name="Pays-Bas">
<region name="Hollande-Méridionale">
<name sortKey="A Ampo, L E I" sort="A Ampo, L E I" uniqKey="A Ampo L" first="L. E. I." last="A Ampo">L. E. I. A Ampo</name>
</region>
<name sortKey="Roos, R A C" sort="Roos, R A C" uniqKey="Roos R" first="R. A. C." last="Roos">R. A. C. Roos</name>
<name sortKey="Spliethoff Amminga, N G A" sort="Spliethoff Amminga, N G A" uniqKey="Spliethoff Amminga N" first="N. G. A." last="Spliethoff-Kamminga">N. G. A. Spliethoff-Kamminga</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000398 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000398 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:EA530E2F07A55D2E676030393FBE701522F932FE
   |texte=   An evaluation of the patient education programme for Parkinson’s disease in clinical practice
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024